<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02454569</url>
  </required_header>
  <id_info>
    <org_study_id>VFHCS</org_study_id>
    <nct_id>NCT02454569</nct_id>
  </id_info>
  <brief_title>Vicente Ferrer HIV Cohort Study</brief_title>
  <acronym>VFHCS</acronym>
  <official_title>Vicente Ferrer HIV Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rural Development Trust Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rural Development Trust Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The VFHCS is a long-term prospective cohort study of HIV infected patients from a
      resource-poor rural setting in India. The aim of the study is to use data collected from
      routine clinical care in order to describe the epidemiology of HIV and its related conditions
      in the investigators area, and to study the effectiveness of health interventions in a
      &quot;real-world&quot; setting (implementation and operational research).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Andhra Pradesh is the state with highest burden of HIV in India. Anantapur is a district
      situated in the South border of Andhra Pradesh with 72% rural population and adult literacy
      rate of 74.1% in men and 54.3% in women. In Anantapur, the HIV epidemic is largely driven by
      heterosexual transmission and it is characterized by poor socioeconomic conditions and high
      levels of illiteracy.

      Rural Development Trust (RDT) is a nongovernmental organization, which provides medical care
      to people living with HIV free of charge, including medicines, consultation and admission
      charges. In Bathalapalli Hospital, outpatient clinics and 71 beds are allocated exclusively
      for HIV or tuberculosis infected patients.

      The Vicente Ferrer HIV Cohort Study (VFHCS) is a prospective open cohort study of all HIV
      infected patients who have attended Bathalapalli RDT Hospital. Routine clinical data from
      patients are collected prospectively since September 2009 and entered in a SQL-server
      database using C# as front end. Details of route of transmission, HIV associated risk factors
      and socio-demographic data are collected at enrolment. Data collected include medical
      treatment (antiretroviral treatment and other medications), laboratory investigations
      (haemogram, renal function tests, liver function tests, CD4 lymphocyte count, bacterial
      infections), and standardized diagnoses.

      The objective of the VFHCS is to describe social and medical aspects related to HIV in the
      investigators setting, including:

        1. Epidemiology: trends in HIV incidence, transmission mechanisms, socioeconomic risk
           factors associated with HIV.

        2. Incidence and prevalence of opportunistic infections, especially tuberculosis and
           cryptococcosis.

        3. Life expectancy and factors associated with mortality

        4. Describe the retention across the continuum of care and investigate factors associated
           with loss to follow-up.

        5. Toxicity and effectiveness of antiretroviral therapy.

        6. Effectiveness of programmes to prevent mother to child transmission.

        7. Incidence and prevalence of non-communicable diseases such as cancer or cardiovascular
           diseases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">January 2040</completion_date>
  <primary_completion_date type="Anticipated">September 2039</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Years</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Time to event methods will be used. Participants will be followed from HIV diagnosis until death, assessed up to 30 years</time_frame>
    <description>Survival since diagnosis of HIV infection</description>
  </primary_outcome>
  <enrollment type="Anticipated">30000</enrollment>
  <condition>HIV</condition>
  <condition>Tuberculosis</condition>
  <condition>Cryptococcosis</condition>
  <condition>Opportunistic Infections</condition>
  <condition>Noncommunicable Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        HIV infected patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive serology for HIV

        Exclusion Criteria:

          -  Refuse to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerardo Alvarez-Uria</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rural Development Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerardo Alvarez-Uria</last_name>
    <email>hivbtp@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>RDT Hospital</name>
      <address>
        <city>Battalapalli</city>
        <state>AP</state>
        <zip>515661</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerardo Alvarez Uria, MD PhD</last_name>
      <email>hivbtp@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gerardo Alvarez-Uria</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Naik PK. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infect Dis Rep. 2012 Feb 17;4(1):e19. doi: 10.4081/idr.2012.e19. eCollection 2012 Jan 2. Review.</citation>
    <PMID>24470926</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Pakam R, Midde M. Early HIV viral load determination after initiating first-line antiretroviral therapy for indentifying patients with high risk of developing virological failure: data from a cohort study in a resource-limited setting. Trop Med Int Health. 2012 Sep;17(9):1152-5. doi: 10.1111/j.1365-3156.2012.02982.x. Epub 2012 Apr 5.</citation>
    <PMID>22487689</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Kannan S, Bachu L, Naik PK. Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India. Interdiscip Perspect Infect Dis. 2012;2012:293795. doi: 10.1155/2012/293795. Epub 2012 Apr 24.</citation>
    <PMID>22611389</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Bachu L, Naik PK. Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Study in India. ISRN Pediatr. 2012;2012:763591. doi: 10.5402/2012/763591. Epub 2012 Jun 3.</citation>
    <PMID>22701801</PMID>
  </results_reference>
  <results_reference>
    <citation>Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JS, Lane HC, Larder BA; RDI Data and Study Group. An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. J Antimicrob Chemother. 2016 Oct;71(10):2928-37. doi: 10.1093/jac/dkw217. Epub 2016 Jun 20.</citation>
    <PMID>27330070</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Naik PK. Mortality in HIV-infected patients with tuberculosis treated with streptomycin and a two-week intensified regimen: data from an HIV cohort study using inverse probability of treatment weighting. PeerJ. 2016 May 17;4:e2053. doi: 10.7717/peerj.2053. eCollection 2016.</citation>
    <PMID>27231666</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Yalla PS, Naik PK, Reddy R. Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis. J Trop Med. 2015;2015:864271. doi: 10.1155/2015/864271. Epub 2015 Sep 10.</citation>
    <PMID>26448766</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Pakam R, Midde M, Yalla PS, Naik PK. Adding Streptomycin to an Intensified Regimen for Tuberculous Meningitis Improves Survival in HIV-Infected Patients. Interdiscip Perspect Infect Dis. 2015;2015:535134. doi: 10.1155/2015/535134. Epub 2015 Aug 4.</citation>
    <PMID>26347376</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Pakam R, Midde M, Naik PK. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India. J Int AIDS Soc. 2014 Dec 9;17:19251. doi: 10.7448/IAS.17.1.19251. eCollection 2014.</citation>
    <PMID>25499123</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Pakam R, Naik PK, Midde M. Induction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus non-nucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older. PLoS One. 2014 Sep 18;9(9):e108063. doi: 10.1371/journal.pone.0108063. eCollection 2014.</citation>
    <PMID>25232730</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Naik PK. Directly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patients. Biomed Res Int. 2014;2014:937817. doi: 10.1155/2014/937817. Epub 2014 Jun 11.</citation>
    <PMID>25013814</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Midde M, Pakam R. Mortality and Loss to Follow up Before Initiation of Antiretroviral Therapy Among HIV-Infected Children Eligible for HIV Treatment. Infect Dis Rep. 2014 May 13;6(2):5167. doi: 10.4081/idr.2014.5167. eCollection 2014 May 13.</citation>
    <PMID>25002959</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G. Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in India. PeerJ. 2014 Mar 13;2:e304. doi: 10.7717/peerj.304. eCollection 2014.</citation>
    <PMID>24688879</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Midde M, Pakam R. Predictors of loss to follow-up after engagement in care of HIV-infected children ineligible for antiretroviral therapy in an HIV cohort study in India. Germs. 2014 Mar 3;4(1):9-15. doi: 10.11599/germs.2014.1049. eCollection 2014 Mar.</citation>
    <PMID>24639956</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Pakam R, Midde M, Naik PK. Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines. Int Sch Res Notices. 2014 Dec 15;2014:704980. doi: 10.1155/2014/704980. eCollection 2014.</citation>
    <PMID>27433510</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Midde M, Pakam R. Predictors of delayed entry into medical care of children diagnosed with HIV infection: data from an HIV cohort study in India. ScientificWorldJournal. 2013 Nov 14;2013:737620. doi: 10.1155/2013/737620. eCollection 2013.</citation>
    <PMID>24348184</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India. Biomed Res Int. 2013;2013:849042. doi: 10.1155/2013/849042. Epub 2013 Oct 29.</citation>
    <PMID>24288689</PMID>
  </results_reference>
  <results_reference>
    <citation>Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JS, Lane HC, Larder BA; RDI Study Group. An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. J Antimicrob Chemother. 2014 Apr;69(4):1104-10. doi: 10.1093/jac/dkt447. Epub 2013 Nov 24.</citation>
    <PMID>24275116</PMID>
  </results_reference>
  <results_reference>
    <citation>Revell AD, Alvarez-Uria G, Wang D, Pozniak A, Montaner JS, Lane HC, Larder BA. Potential impact of a free online HIV treatment response prediction system for reducing virological failures and drug costs after antiretroviral therapy failure in a resource-limited setting. Biomed Res Int. 2013;2013:579741. doi: 10.1155/2013/579741. Epub 2013 Sep 24.</citation>
    <PMID>24175292</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Naik PK. Diagnostic and Prognostic Value of Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy: Datafrom an HIV Cohort Study in India. Bioimpacts. 2013;3(3):123-8. doi: 10.5681/bi.2013.025. Epub 2013 Sep 1.</citation>
    <PMID>24163804</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Naik PK. Predictors of attrition in patients ineligible for antiretroviral therapy after being diagnosed with HIV: data from an HIV cohort study in India. Biomed Res Int. 2013;2013:858023. doi: 10.1155/2013/858023. Epub 2013 Aug 29.</citation>
    <PMID>24069604</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Pakam R, Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 2013 Sep 12;6:21682. doi: 10.3402/gha.v6i0.21682.</citation>
    <PMID>24028937</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Pakam R, Naik PK. Initial Antituberculous Regimen with Better Drug Penetration into Cerebrospinal Fluid Reduces Mortality in HIV Infected Patients with Tuberculous Meningitis: Data from an HIV Observational Cohort Study. Tuberc Res Treat. 2013;2013:242604. doi: 10.1155/2013/242604. Epub 2013 Aug 20.</citation>
    <PMID>23997952</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Pakam R, Midde M, Naik PK. Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries. Interdiscip Perspect Infect Dis. 2013;2013:384805. doi: 10.1155/2013/384805. Epub 2013 Jul 10.</citation>
    <PMID>23935613</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G. Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: Data from a cohort study in India. PeerJ. 2013 Jun 18;1:e90. doi: 10.7717/peerj.90. Print 2013.</citation>
    <PMID>23802091</PMID>
  </results_reference>
  <results_reference>
    <citation>Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing AM, DeWolf F, Nelson M, Montaner JS, Lane HC, Larder BA; RDI study group. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. J Antimicrob Chemother. 2013 Jun;68(6):1406-14. doi: 10.1093/jac/dkt041. Epub 2013 Mar 13.</citation>
    <PMID>23485767</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Pakam R, Bachu L, Midde M. Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India. Interdiscip Perspect Infect Dis. 2012;2012:502012. doi: 10.1155/2012/502012. Epub 2012 Dec 18.</citation>
    <PMID>23316226</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India. Tuberc Res Treat. 2012;2012:932862. doi: 10.1155/2012/932862. Epub 2012 Aug 26.</citation>
    <PMID>22966426</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Naik PK. Socio-demographic Risk Factors Associated with HIV Infection In Patients Seeking Medical Advice in a Rural Hospital of India. J Public Health Res. 2012 Feb 14;1(1):79-82. doi: 10.4081/jphr.2012.e14. eCollection 2012 Feb 17.</citation>
    <PMID>25170450</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Naik PK, Midde M, Kannan S, Reddy R. False negative HIV antibody test in HIV infected children who receive early antiretroviral treatment in a resource-limited setting. Infect Dis Rep. 2012 Jan 4;4(1):e6. doi: 10.4081/idr.2012.e6. eCollection 2012 Jan 2.</citation>
    <PMID>24470936</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Reddy R, Reddy S, Naik PK, Midde M. Evaluation of a Low-Cost Strategy for Enumerating CD4 Lymphocyte Absolute Count and Percentage Using the FACSCalibur Flow Cytometer in HIV-Infected Patients from a Resource-Limited Setting. ISRN AIDS. 2012 Oct 23;2012:494698. doi: 10.5402/2012/494698. eCollection 2012.</citation>
    <PMID>24052877</PMID>
  </results_reference>
  <results_reference>
    <citation>Alvarez-Uria G, Midde M, Naik PK. Trends and risk factors for HIV infection among young pregnant women in rural India. Int J Infect Dis. 2012 Feb;16(2):e121-3. doi: 10.1016/j.ijid.2011.10.003. Epub 2011 Dec 5.</citation>
    <PMID>22153000</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rural Development Trust Hospital</investigator_affiliation>
    <investigator_full_name>Gerardo Alvarez-Uria</investigator_full_name>
    <investigator_title>Head of the Department of Infectious Diseases</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Opportunistic Infections</mesh_term>
    <mesh_term>Cryptococcosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

